Email This Article

Headlines & Perspectives
Vytorin Risks Debated in Medical Journal
By Elizabeth Trotta
09/02/08 - 02:29 PM EDT
The cholesterol drug, produced by Schering-Plough and Merck, produced a higher rate of cancer vs. a control group in a recent study, but a larger analysis said the results are statistically insignificant.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,309.92 1,091.49 2,138.44 32.12
Oil *
77.09
DOWN
154.48
DOWN
19.14
DOWN
37.61
DOWN
0.67
10 Yr
3.21%
SPDR Gold
115.06
-1.48%
-1.72%
-1.73%
-2.04%
Data delayed 20 minutes

Brokerage Partners